Frazier Lifesciences Acquisition Corp. (FLAC)
NASDAQ: FLAC · IEX Real-Time Price · USD
9.86
0.00 (0.00%)
May 27, 2022 10:54 AM EDT - Market open
| Market Cap | 175.02M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | 2.75M |
| Shares Out | 17.75M |
| EPS (ttm) | 0.16 |
| PE Ratio | 63.61 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,724 |
| Open | 9.86 |
| Previous Close | 9.86 |
| Day's Range | 9.86 - 9.86 |
| 52-Week Range | 9.65 - 10.02 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About FLAC
Frazier Lifesciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities in the biotechnology sector. The company was incorporated in 2020 and is based in Seattle, Washington.
IndustryBlank Check / SPAC
IPO DateDec 9, 2020
Employees4
Stock ExchangeNASDAQ
Ticker SymbolFLAC
Financial Performance
Financial StatementsNews
Frazier Lifesciences Acquisition Corporation Announces Pricing of Upsized $120 Million Initial Public Offering
MENLO PARK, Calif.--(BUSINESS WIRE)--Frazier Healthcare Partners' special purpose acquisition corporation, Frazier Lifesciences Acquisition Corporation, announced the pricing of its initial public offer...
1 year ago - Business Wire